Using exome sequencing data from four cancers with origins to NTC and NCC, a ‘signature’ of loci significant to each cancer (p-value ≤ 0.01) was created and compared with previously identified CAML from breast cancer. The gene discussed is CAMLG; the disease is breast cancer.